Topic · page 56 of 64

Obesity

Overweight and obesity in adults and children: weight-lowering drugs, lifestyle, metabolic and bariatric surgery against other treatment, weight-related disease, lipodystrophy

Briefs 2,201–2,240 of 2,541 placed here, newest publication first

Briefs in Obesity

Newest publication first

Int J Obes (Lond)1 Jul 2023
Non-traditional data sources in obesity research: a systematic review of their use in the study of obesogenic environments
Meta-analysis
Obesity (Silver Spring)30 Jun 2023
No strong evidence of the protein leverage hypothesis in pregnant women with obesity and their infants
Cohort study
Endocr Pract28 Jun 2023
Changes in Urinary Iodine Levels Following Bariatric Surgery
Cohort study
Obesity (Silver Spring)27 Jun 2023
Characterizing regional and global effects of epicardial adipose tissue on cardiac systolic and diastolic function
Cross-sectional study
Obesity (Silver Spring)27 Jun 2023
The effect of weight loss on whole‐body and tissue‐specific insulin sensitivity and hepatic lipid content and composition: SWEET substudy
Secondary analysis
Obesity (Silver Spring)27 Jun 2023
Lower abdominal adipose tissue cannabinoid type 1 receptor availability in young men with overweight
Cross-sectional study
Int J Obes (Lond)27 Jun 2023
Is being childless associated with a woman’s risk of overweight and obesity? Results from a national longitudinal study
Cohort study
Ann Intern Med27 Jun 2023
Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial
Randomized controlled trial
N Engl J Med26 Jun 2023
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Randomized controlled trial
Lancet26 Jun 2023
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Randomized controlled trial
Lancet26 Jun 2023
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Randomized controlled trial
Diabetes Res Clin Pract24 Jun 2023
Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review
Meta-analysis
N Engl J Med23 Jun 2023
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Randomized controlled trial
Diabetes Obes Metab21 Jun 2023
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison
Research article
Diabetes Obes Metab19 Jun 2023
Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three‐arm crossover trial
Randomized controlled trial
J Clin Endocrinol Metab17 Jun 2023
Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar
Cross-sectional study
Obesity (Silver Spring)15 Jun 2023
Risk factors for obesity in adulthood among survivors of childhood cancer
Cohort study
N Engl J Med15 Jun 2023
Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity
Research article
Obesity (Silver Spring)14 Jun 2023
Placental epigenetic marks related to gestational weight gain reveal potential genes associated with offspring obesity parameters
Mechanistic study
Diabetes Obes Metab13 Jun 2023
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long‐acting glucagon analogue HM15136 in overweight and obese patients with co‐morbidities
Randomized controlled trial
JAMA13 Jun 2023
Family-Based Behavioral Treatment for Childhood Obesity Implemented in Pediatric Primary Care: A Randomized Clinical Trial
Randomized controlled trial
Obesity (Silver Spring)13 Jun 2023
The cross‐sectional association between a sustainable diet index and obesity among US adults
Cross-sectional study
Pediatr Obes13 Jun 2023
Hyperglycemia: A determinant of cardiac autonomic dysfunction in youth with obesity across the spectrum of glycemic regulation
Cross-sectional study
Diabetes Obes Metab13 Jun 2023
Sumatriptan, a serotonin 5HT 1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double‐blinded placebo‐controlled cross‐over trial
Randomized controlled trial
J Clin Endocrinol Metab10 Jun 2023
Obesity, Hyperfiltration, and Early Kidney Damage: A New Formula for the Estimation of Creatinine Clearance
Diagnostic or prognostic study
Pediatr Obes8 Jun 2023
Infant effortful control predicts BMI trajectories from infancy to adolescence
Cohort study
Diabetes Obes Metab7 Jun 2023
Weight change and risk of obesity‐related complications: A retrospective population‐based cohort study of a UK primary care database
Cohort study
Pediatr Obes6 Jun 2023
Relationships examined: Parent and child readiness to change and sociodemographic characteristics in family based weight loss treatment
Cross-sectional study
Diabetes Obes Metab5 Jun 2023
Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION‐DK study
Cross-sectional study
Diabetes Technol Ther5 Jun 2023
Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass
Randomized controlled trial
Obesity (Silver Spring)4 Jun 2023
How much food tracking during a digital weight‐management program is enough to produce clinically significant weight loss?
Secondary analysis
Diabetes Res Clin Pract3 Jun 2023
The effects of exercise training on postprandial glycemia and insulinemia in adults with overweight or obesity and with cardiometabolic disorders: A systematic review and meta-analysis
Meta-analysis
Pediatr Obes1 Jun 2023
The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity
Cohort study
Pediatr Obes1 Jun 2023
Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo‐controlled SCALE Teens trial
Secondary analysis
Int J Obes (Lond)31 May 2023
Obesity-related complications, healthcare resource use and weight loss strategies in six European countries: the RESOURCE survey
Cross-sectional study
Int J Obes (Lond)31 May 2023
Efficacy and safety of tirzepatide for treatment of overweight or obesity. A systematic review and meta-analysis
Meta-analysis
Diabetes Obes Metab31 May 2023
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta‐analysis of randomized controlled trials
Meta-analysis
Diabetes Obes Metab29 May 2023
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
Research article
Obesity (Silver Spring)25 May 2023
Proatherogenic changes in lipoprotein particles associated with a high triglyceride to high‐density lipoprotein cholesterol ratio in youths
Cross-sectional study
J Clin Endocrinol Metab25 May 2023
Association Between Markers of Adiposity During Childhood and Puberty Onset in Latino Girls
Cohort study

All 2,541 Briefs in ExploreShowing Briefs 2,201–2,240 of 2,541, newest first